ArticleHuman vaccines & immunotherapeutics2023

Structure-based design of oligomeric receptor-binding domain (RBD) recombinant proteins as potent vaccine candidates against SARS-CoV-2.

Ting Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.